About

Prof. Dr. Med. Andreas Kulozik is a seasoned medical practitioner globally recognized for providing care and treatment to adults, children, and infants suffering from congenital and acquired lung, blood vessels, and autoimmune disorders. Dr. Med. Andreas Kulozik is Medical Director of the Department of Pediatric Oncology, Hematology, Immunology, and Pulmonology at Heidelberg University Hospital, Germany. The department is considered a pioneer in providing medical facilities in this field and treats more than 1500 patients annually under Dr. Andreas Kulozik. Dr. Med. Andreas Kulozik is specialized in the diagnosis and medication of the following diseases and treated thousands of patients in the last three decades: • Brain tumor • Anemia • Blood clotting disorders • Osteosarcoma • Chronic cough • Bronchitis • Cystic fibrosis • Bronchial asthma • Eczema • Tuberculosis • Liver cancer • Lung cancer • Soft tissue cancer • Leukemia • Bone marrow disorders Dr. Med. Andreas Kulozik is a highly qualified professional with years of education, training, and experience. He did his early medical studies at the Universities of Munster and Glasgow and acquired the license to practice medicine in 1984. He finished his Doctor of Medicine degree in 1985 from the Institute for Human Genetics, University of Munster. Dr. Andreas Kulozik then went to the UK for further education and earned a Ph.D. from the MRC Molecular Haematology Unit, Nuffield Department of Medicine, University of Oxford. During 1994-1996, Dr. Andreas Kulozik worked as a Senior Physician at the Pediatric Hospital, Charite, Berlin. He also taught as a University Professor for Pediatrics in Berlin from 1996 till 2001. Currently, he is Medical Director of Children’s Hospital (Unit 3), Heidelberg University Hospital, Co-Director of Molecular Medicine Partnership (MMPU), and Director of the Children’s Cancer Center (Kindertumorzentrum, Kitz) Heidelberg. In addition to his extensive clinical practice and teaching, Dr. Med. Andreas Kulozik is also an active member of many national and international medical associations related to hematology, oncology, and molecular biology and won various awards for his achievements.